Clinical Trials Directory

Trials / Completed

CompletedNCT01580085

Obstructive Sleep Apnea in Pulmonary Embolism

Obstructive Sleep Apnea is Prevalent in Patients With Pulmonary Embolism

Status
Completed
Phase
Study type
Observational
Enrollment
75 (actual)
Sponsor
University of Gaziantep · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Obstructive sleep apnea (OSA) is a clinical syndrome characterized by repetitive closure of the airway and frequent awakenings during sleep. Repeated episodes of hypoxia, decrease in intrathoracic pressure, increased venous return and venous stasis, damage to vascular wall may ensue. An increased tendency for coagulation has also been reported in OSA. Venous stasis, vascular endothelial activation and hypercoagulability are also known risk factors for thromboembolism. All of these pathophysiologic changes in OSA may predispose patients for the development of pulmonary embolism (PE) however there is limited data about role of thromboembolic events in OSA.

Conditions

Interventions

TypeNameDescription
OTHERpolysomnographyfull night supervised laboratory polysomnography

Timeline

Start date
2009-11-01
Primary completion
2010-12-01
Completion
2010-12-01
First posted
2012-04-18
Last updated
2012-04-18

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT01580085. Inclusion in this directory is not an endorsement.